US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist

8.980
+0.090+1.01%

Close May 14 16:00 ET

870.12MMarket Cap-17269P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

46.01%-6.71M

-47.88%-59.27M

15.09%-17.41M

-124.62%-12.76M

-139.02%-16.67M

-79.48%-12.43M

-128.22%-40.08M

-20.5M

-5.68M

-6.97M

Net income from continuing operations

31.21%-10.29M

-56.75%-54.37M

50.32%-7.17M

-125.82%-14.87M

-170.56%-17.37M

-106.36%-14.96M

-71.33%-34.68M

---14.43M

---6.58M

---6.42M

Operating gains losses

----

3,600.00%140K

--143K

--0

---2K

Depreciation and amortization

-10.06%-1.97M

-2,233.23%-6.81M

-2,396.32%-6.87M

200.00%21K

5,043.24%1.83M

-3,678.00%-1.79M

49.77%319K

--299K

--7K

---37K

Other non cash items

----

--1.06M

--931K

--40K

----

Change In working capital

7.97%2.24M

42.52%-7.33M

11.75%-10.77M

162.18%1.03M

135.04%335K

17,158.33%2.07M

-3,482.58%-12.75M

---12.2M

--394K

---956K

-Change in prepaid assets

94.83%867K

-20.99%-1.44M

-60.74%-1.92M

-163.77%-88K

155.36%124K

383.70%445K

-201.11%-1.19M

---1.19M

--138K

---224K

-Change in payables and accrued expense

-71.74%1.34M

73.00%-2.78M

22.25%-8.88M

30.85%1.12M

183.90%224K

771.06%4.76M

-1,155.95%-10.29M

---11.42M

--859K

---267K

-Change in other working capital

100.80%25K

-143.10%-3.12M

-67.47%27K

98.91%-3K

97.20%-13K

-400.00%-3.13M

48.74%-1.28M

--83K

---275K

---465K

Cash from discontinued investing activities

Operating cash flow

46.01%-6.71M

-47.88%-59.27M

15.09%-17.41M

-124.62%-12.76M

-139.02%-16.67M

-79.48%-12.43M

-128.22%-40.08M

---20.5M

---5.68M

---6.97M

Investing cash flow

Cash flow from continuing investing activities

92.37%-8.51M

-43,709.05%-87.18M

20,765.87%26.04M

-155,376.67%-46.64M

204,509.09%44.97M

-531,071.43%-111.55M

-261.82%-199K

-126K

-30K

-22K

Net PPE purchase and sale

56.99%-83K

12.06%-175K

172.22%91K

-43.33%-43K

-36.36%-30K

-819.05%-193K

-261.82%-199K

---126K

---30K

---22K

Net investment purchase and sale

92.43%-8.43M

---87.01M

--25.95M

---46.6M

--45M

---111.35M

--0

Cash from discontinued investing activities

Investing cash flow

92.37%-8.51M

-43,709.05%-87.18M

20,765.87%26.04M

-155,376.67%-46.64M

204,509.09%44.97M

-531,071.43%-111.55M

-261.82%-199K

---126K

---30K

---22K

Financing cash flow

Cash flow from continuing financing activities

-80.44%258K

-96.38%6.9M

-99.07%1.81M

159.19%921K

558.11%2.85M

245.26%1.32M

258.80%190.73M

193.82M

-1.56M

-623K

Net issuance payments of debt

----

--0

----

-377.77%-8.68M

---5.95M

---909K

---910K

Proceeds from stock option exercised by employees

-80.44%258K

1,110.35%6.9M

537.81%1.81M

--921K

894.43%2.85M

--1.32M

237.28%570K

--283K

--0

--287K

Net other financing activities

----

--198.84M

--199.49M

----

Cash from discontinued financing activities

Financing cash flow

-80.44%258K

-96.38%6.9M

-99.07%1.81M

159.19%921K

558.11%2.85M

245.26%1.32M

258.80%190.73M

--193.82M

---1.56M

---623K

Net cash flow

Beginning cash position

-66.29%70.97M

250.50%210.52M

62.19%60.53M

166.91%119.02M

68.29%87.86M

250.50%210.52M

144.95%60.06M

--37.32M

--44.59M

--52.21M

Current changes in cash

87.80%-14.97M

-192.75%-139.55M

-93.97%10.44M

-704.69%-58.49M

508.91%31.16M

-1,461.70%-122.66M

323.32%150.46M

--173.2M

---7.27M

---7.62M

End cash Position

-36.26%56.01M

-66.29%70.97M

62.19%60.53M

166.91%119.02M

68.29%87.86M

250.50%210.52M

--210.52M

--37.32M

--44.59M

Free cash flow

46.18%-6.79M

-47.58%-59.44M

16.05%-17.31M

-124.19%-12.81M

-138.69%-16.7M

-81.72%-12.62M

-128.64%-40.28M

---20.62M

---5.71M

---7M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	46.01%-6.71M	-47.88%-59.27M	15.09%-17.41M	-124.62%-12.76M	-139.02%-16.67M	-79.48%-12.43M	-128.22%-40.08M	-20.5M	-5.68M	-6.97M
Net income from continuing operations	31.21%-10.29M	-56.75%-54.37M	50.32%-7.17M	-125.82%-14.87M	-170.56%-17.37M	-106.36%-14.96M	-71.33%-34.68M	---14.43M	---6.58M	---6.42M
Operating gains losses	----	----	----	----	----	----	3,600.00%140K	--143K	--0	---2K
Depreciation and amortization	-10.06%-1.97M	-2,233.23%-6.81M	-2,396.32%-6.87M	200.00%21K	5,043.24%1.83M	-3,678.00%-1.79M	49.77%319K	--299K	--7K	---37K
Other non cash items	----	----	----	----	----	----	--1.06M	--931K	--40K	----
Change In working capital	7.97%2.24M	42.52%-7.33M	11.75%-10.77M	162.18%1.03M	135.04%335K	17,158.33%2.07M	-3,482.58%-12.75M	---12.2M	--394K	---956K
-Change in prepaid assets	94.83%867K	-20.99%-1.44M	-60.74%-1.92M	-163.77%-88K	155.36%124K	383.70%445K	-201.11%-1.19M	---1.19M	--138K	---224K
-Change in payables and accrued expense	-71.74%1.34M	73.00%-2.78M	22.25%-8.88M	30.85%1.12M	183.90%224K	771.06%4.76M	-1,155.95%-10.29M	---11.42M	--859K	---267K
-Change in other working capital	100.80%25K	-143.10%-3.12M	-67.47%27K	98.91%-3K	97.20%-13K	-400.00%-3.13M	48.74%-1.28M	--83K	---275K	---465K
Cash from discontinued investing activities
Operating cash flow	46.01%-6.71M	-47.88%-59.27M	15.09%-17.41M	-124.62%-12.76M	-139.02%-16.67M	-79.48%-12.43M	-128.22%-40.08M	---20.5M	---5.68M	---6.97M
Investing cash flow
Cash flow from continuing investing activities	92.37%-8.51M	-43,709.05%-87.18M	20,765.87%26.04M	-155,376.67%-46.64M	204,509.09%44.97M	-531,071.43%-111.55M	-261.82%-199K	-126K	-30K	-22K
Net PPE purchase and sale	56.99%-83K	12.06%-175K	172.22%91K	-43.33%-43K	-36.36%-30K	-819.05%-193K	-261.82%-199K	---126K	---30K	---22K
Net investment purchase and sale	92.43%-8.43M	---87.01M	--25.95M	---46.6M	--45M	---111.35M	--0	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	92.37%-8.51M	-43,709.05%-87.18M	20,765.87%26.04M	-155,376.67%-46.64M	204,509.09%44.97M	-531,071.43%-111.55M	-261.82%-199K	---126K	---30K	---22K
Financing cash flow
Cash flow from continuing financing activities	-80.44%258K	-96.38%6.9M	-99.07%1.81M	159.19%921K	558.11%2.85M	245.26%1.32M	258.80%190.73M	193.82M	-1.56M	-623K
Net issuance payments of debt	----	--0	--0	--0	----	----	-377.77%-8.68M	---5.95M	---909K	---910K
Proceeds from stock option exercised by employees	-80.44%258K	1,110.35%6.9M	537.81%1.81M	--921K	894.43%2.85M	--1.32M	237.28%570K	--283K	--0	--287K
Net other financing activities	----	----	----	----	----	----	--198.84M	--199.49M	----	----
Cash from discontinued financing activities
Financing cash flow	-80.44%258K	-96.38%6.9M	-99.07%1.81M	159.19%921K	558.11%2.85M	245.26%1.32M	258.80%190.73M	--193.82M	---1.56M	---623K
Net cash flow
Beginning cash position	-66.29%70.97M	250.50%210.52M	62.19%60.53M	166.91%119.02M	68.29%87.86M	250.50%210.52M	144.95%60.06M	--37.32M	--44.59M	--52.21M
Current changes in cash	87.80%-14.97M	-192.75%-139.55M	-93.97%10.44M	-704.69%-58.49M	508.91%31.16M	-1,461.70%-122.66M	323.32%150.46M	--173.2M	---7.27M	---7.62M
End cash Position	-36.26%56.01M	-66.29%70.97M	-66.29%70.97M	62.19%60.53M	166.91%119.02M	68.29%87.86M	250.50%210.52M	--210.52M	--37.32M	--44.59M
Free cash flow	46.18%-6.79M	-47.58%-59.44M	16.05%-17.31M	-124.19%-12.81M	-138.69%-16.7M	-81.72%-12.62M	-128.64%-40.28M	---20.62M	---5.71M	---7M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall